Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 108,520 | 121,510 | 226,102 | 140,774 | 54,152 |
Receivables | 52,491 | 56,939 | 44,691 | 32,381 | 17,099 |
Inventories | 107,789 | 134,608 | 136,643 | 67,183 | 81,346 |
Other current assets | 2,870 | 3,569 | 3,654 | 9,129 | 6,741 |
TOTAL | $278,087 | $326,046 | $421,755 | $249,467 | $159,338 |
Non-Current Assets | |||||
PPE Net | 368,308 | 379,722 | 369,092 | 228,804 | 155,839 |
Investments And Advances | 730 | 1,228 | 5,912 | 4,360 | 1,278 |
Intangibles | 576,663 | 738,145 | 884,411 | 646,110 | 231,925 |
Other Non-Current Assets | 134,679 | 138,551 | 99,293 | 103,855 | 68,174 |
TOTAL | $1,080,380 | $1,257,646 | $1,358,708 | $983,129 | $457,216 |
Total Assets | $1,358,467 | $1,583,692 | $1,780,463 | $1,232,596 | $616,554 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 11,817 | 10,976 | 19,928 | 25,924 | N/A |
Accounts payable and accrued liabilities | 27,587 | 28,093 | 32,278 | 23,231 | 62,834 |
Accrued Expenses | 69,079 | 65,161 | 95,442 | 130,469 | N/A |
Other current liabilities | N/A | N/A | 1,172 | N/A | 178 |
TOTAL | $200,242 | $255,865 | $288,394 | $252,846 | $150,169 |
Non-Current Liabilities | |||||
Long Term Debt | 497,713 | 476,891 | 465,079 | 255,439 | 550 |
Deferred Revenues | N/A | 47,834 | 71,833 | 19,115 | 59,940 |
aiOther Non-Current Liabilities | 25,930 | 10,796 | -15,762 | 16,676 | 37,344 |
TOTAL | $730,158 | $740,144 | $694,333 | $404,418 | $143,762 |
Total Liabilities | $930,400 | $996,009 | $982,727 | $657,264 | $293,931 |
Shareholders' Equity | |||||
Common Shares | 1,689,452 | 1,617,093 | 1,597,715 | 802,264 | 275,851 |
Retained earnings | -1,265,536 | -1,076,198 | -841,907 | -328,380 | -114,632 |
Other shareholders' equity | -78,776 | -40,749 | 41,928 | 101,448 | 135,541 |
TOTAL | $428,067 | $587,683 | $797,736 | $575,332 | $322,623 |
Total Liabilities And Equity | $1,358,467 | $1,583,692 | $1,780,463 | $1,232,596 | $616,554 |